Charles McOsker, Ph.D.

Charles McOsker, Ph.D.

Co-founder & Chief Scientific Officer

Charles McOsker, Ph.D., is a veteran scientific executive with over 30 years of experience in drug discovery and development. Before joining Clarametyx, Dr. McOsker was Chief Technical Operations Officer at BioMotiv, which identifies and accelerates the development of breakthrough new therapeutics. Previously, Dr. McOsker founded Airway Therapeutics, which was created to develop pulmonary therapeutics based on the pulmonary research program at Cincinnati Children’s Hospital. Dr. McOsker has also served as Director of Business Development for the Drug Discovery Center at the University of Cincinnati. Dr. McOsker began his career at Procter & Gamble Pharmaceuticals, where he held both research and management positions in drug discovery and development over his 23-year tenure. Dr. McOsker received his bachelor’s degree in chemistry at Hope College in Michigan and his Ph.D. in biochemistry and molecular biology at Cornell University.